Liverpool COVID-19 Interactions
STEP-WISE APPROACH TO INITIATING HEPATITIS C VIRUS (HCV) TREATMENT IN PRIMARY CARE SETTINGS
Liverpool HEP Interactions
Kate Drysdale on Twitter: "Always good to find new evidence in the posters. Especially when it can be used in practice straight away! @hepinteractions data show no need to defer #HCV treatment
Liverpool recognised for HIV pharmacology research - News - University of Liverpool
Liverpool HEP iChart - Apps on Google Play
Liverpool University HIV/HEP/Cancer Drug Interactions
Risk of multiple drug-drug interactions (DDIs) in HCV patients receiving pangenotypic DAAs (pDAAs): A complex drug interaction scenario first time evaluated in German patients
HEP Drug Interactions
Drug Interactions | The Well Project
Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians
Part 3. Curing hepatitis C in general practice | Medicine Today
Epclusa patients
Lesson 4: Test Your Knowledge - ppt download
Frequency and impact of potential multiple drug-drug interactions (DDIs) associated with pangenotypic direct-acting antivirals in patients receiving opioid substitution therapy
Management of Chronic Hepatitis C in Adults 2019(18).pdf
Epclusa patients
ASHM on Twitter: "@LivUni in conjunction with @ASHMMedia and @INHepSU have released a new resource that aims to help health professionals interpret the University of Liverpool Hep Drug-Drug Interactions Website and App;
Hep Drug Interactions on Twitter: "We've updated https://t.co/0sfSojJyBU to highlight our full range of resources, including educational videos and printable charts about HCV prescribing. Here's the new page and one of our
Interpreting the Liverpool Hep Interactions Checker | ASHM
New Cancer Drug Interactions Resource launched - News - University of Liverpool
